Keeping Current
Targeted Therapies for NSCLC: Where Are We Today?
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:38:01
- Mas informaciones
Informações:
Sinopsis
Are you up to date with therapy strategies for ALK translocation and EGFR mutation–positive non-small cell lung cancer? Credit available for this activity expires: 9/10/26 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1002896?ecd=bdc_podcast_libsyn_mscpedu
